Emerald collaborates with De Montfort University on ongoing research into bioavailability, absorption, and nutritional guidance. This page describes that work plainly — what it is, what it means, and what it does not.
Most supplement brands write their own science. We wanted independent academic input — researchers whose work is to examine nutritional inputs under controlled, published conditions.
Our ongoing programme with De Montfort University is supported through the university's Higher Education Innovation Funding and led by researchers in vascular and metabolic health. It is not a marketing exercise.
Factual profiles. No implied endorsement of the product as clinically concluded.
Senior researcher at De Montfort University with expertise in vascular and metabolic health. Leading the research examining cellular vascular effects of Emerald Nutrition's formula — supported by DMU's Higher Education Innovation Funding and undertaken by PhD candidate Dolgormaa Janchivlamden.
Senior lecturer and researcher at De Montfort University. Focus on natural bioactive compounds — polyphenols, omega 3 — and how they support vascular and muscular health. Provides ongoing nutritional guidance informing Emerald's formulation approach.
A small panel of academic and clinical advisors who review formulation decisions, dosing rationale, and supplier specifications before any change reaches the product. We name and quote them only with permission, on completed work — not as marketing endorsement.
Most supplement research stops at the supplier's ingredient-level studies. We're taking the next step — examining how the assembled Emerald formula behaves, first in human cells at the DMU labs, then in a live UK population via DP Sports Clinic.
Across cellular-level assays conducted at the De Montfort University labs, the research team examined how Emerald's formula behaves in living human cells.
Early findings — promising but not conclusive at this stage — include:
These are pre-clinical, cellular-level findings — not clinical endpoints. They are the kind of signals that justify investing in a live human study. The Phase 1 work informs our understanding of how the formula behaves at the cellular level; it does not establish health outcomes in real-world use.
A single-arm qualitative study examining the daily-use experience of Emerald Supergreens across 50–55 UK participants, run with DP Sports Clinic, who provide the participant population.
The protocol is run independently of Emerald Nutrition. We provide product; DMU and DP Sports Clinic run the work; results are theirs to publish whatever they show.
Phase 2 focuses on real-world participant experience — daily-use sustainability, perceived energy, gut comfort, qualitative wellbeing — rather than clinical endpoints. The work complements (does not replace) the cellular-level evidence from Phase 1.
Four workstreams informing Emerald's formulation. Each one is ongoing — not concluded.
Examining how the body takes up and utilises the ingredients in the formula.
The effect of the pre- and probiotic blend on digestive function and diversity.
Nootropic and phytonutrient roles in clarity, focus, and cellular vascular health.
Research-driven refinement of dosing, synergy, and long-term formulation strategy.
Academic links inform our approach. They do not imply unsupported endorsement, finished clinical conclusions, or health claims. We publish inputs — studies, dosing rationale, testing — and let the reader draw their own conclusions.
Research is a discipline, not a marketing angle.
Academic input shapes the discipline. The scoop is where it lands.
